You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

ACCORD HLTHCARE Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ACCORD HLTHCARE, and what generic and branded alternatives to ACCORD HLTHCARE drugs are available?

ACCORD HLTHCARE has one hundred and fifty-four approved drugs.

There are three tentative approvals on ACCORD HLTHCARE drugs.

Summary for ACCORD HLTHCARE

US Patents:	0
Tradenames:	131
Ingredients:	128
NDAs:	154

Drugs and US Patents for ACCORD HLTHCARE

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Accord Hlthcare	VILAZODONE HYDROCHLORIDE	vilazodone hydrochloride	TABLET;ORAL	208209-003	Apr 27, 2021	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Accord Hlthcare	OXALIPLATIN	oxaliplatin	INJECTABLE;INTRAVENOUS	207474-001	Mar 21, 2017	AP	RX	No	No		⤷ Subscribe				⤷ Subscribe
Accord Hlthcare	BENDAMUSTINE HYDROCHLORIDE	bendamustine hydrochloride	POWDER;INTRAVENOUS	205574-002	Dec 7, 2022	AP	RX	No	No		⤷ Subscribe				⤷ Subscribe
Accord Hlthcare	ROPINIROLE HYDROCHLORIDE	ropinirole hydrochloride	TABLET;ORAL	204022-002	Feb 28, 2017	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Accord Hlthcare	DILTIAZEM HYDROCHLORIDE	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	206997-003	Apr 28, 2020	AB2	RX	No	No		⤷ Subscribe				⤷ Subscribe
Accord Hlthcare	AMITRIPTYLINE HYDROCHLORIDE	amitriptyline hydrochloride	TABLET;ORAL	202446-006	Jun 4, 2014	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for ACCORD HLTHCARE drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	for Injection	100 mcg/vial and 500 mcg/vial	➤ Subscribe	2015-04-14
➤ Subscribe	for Injection	200 mcg/vial	➤ Subscribe	2015-05-01

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.